Partnering Bootcamp Kicks Off ChinaBio® Partnering Forum 2012 in Suzhou CARLSBAD, Calif. & SUZHOU, China–(BUSINESS WIRE)–ChinaBio® Partnering Forum 2012 will be held at the Kempinski Hotel Suzhou May 23–24 in Suzhou, China with a special Partnering Bootcamp – a half-day pre-conference program – held May 22. Array BioPharma and Genentech’s Strategic Alliance Voted Breakthrough Alliance [...]

Vascular Expert Supports FDA Warning about Experimental Therapy for MS Patients MIAMI–(BUSINESS WIRE)–Vascular expert Barry Katzen, M.D., pushes for new clinical trials to confirm experimental hi-risk therapy benefits multiple sclerosis patients. Galectin Therapeutics Reports First Quarter 2012 Financial Results NEWTON, Mass.–(BUSINESS WIRE)–Galectin Therapeutics announces first quarter 2011 results. FDA Advisory Committee Supports Approval of Gilead’s [...]

FDA Advisory Committee Supports Approval of Gilead’s Truvada® for Reducing the Risk of Acquiring HIV FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to support approval of once-daily oral Truvada® (emtricitabine and tenofovir disoproxil fumarate) to reduce the [...]

FDA Advisory Committee Supports Approval of Gilead’s Truvada® for Reducing the Risk of Acquiring HIV FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to support approval of once-daily oral Truvada® (emtricitabine and tenofovir disoproxil fumarate) to reduce the [...]

McKesson Corporation to Present at the Bank of America Merrill Lynch Health Care Conference SAN FRANCISCO–(BUSINESS WIRE)–McKesson Corporation (NYSE:MCK) today announced that Jeff Campbell, executive vice president and chief financial officer, will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas at 1:40 p.m. PT on Tuesday, May 15, 2012. [...]

ChinaBio® Partnering Forum 2012 In Suzhou Brings Big Pharma Companies to China CARLSBAD, Calif. & SUZHOU, China–(BUSINESS WIRE)–The international biotech and pharma community will converge upon the city of Suzhou, China, a rapidly growing base for life science industries, at ChinaBio® Partnering Forum 2012 on May 23 & 24. PerkinElmer Announces Agreement with Macrogen, Inc. [...]

Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia MARLBOROUGH, Mass.–(BUSINESS WIRE)–Sunovion has announced that the US FDA has approved an expanded dose range for LATUDA (lurasidone HCl) in the treatment of adult patients with schizophrenia. Digest powered by RSS Digest

Preliminary Results of Prospective Trial Suggest Warfarin May Be a Safer Option for Patients than Alternative Therapies WALTHAM, Mass.–(BUSINESS WIRE)–Study compares Warfarin and Dabigatran. SDIX to Report First Quarter 2012 Results on May 10, 2012 NEWARK, Del.–(BUSINESS WIRE)–SDIX (Nasdaq: SDIX) – a leading provider of biotechnology-based products and services for a broad range of life [...]

Rite Aid Prices Add-on Offering of Senior Notes CAMP HILL, Pa.–(BUSINESS WIRE)–Rite Aid Corporation (NYSE: RAD) announced today the pricing of an offering of an additional $421.0 million aggregate principal amount of 9.25% senior notes due 2020 (the “Notes”) at a price of 101.25% which will result in total proceeds of approximately $426.3 million. The [...]

Dohmen CEO Cynthia LaConte Named Ernst and Young Entrepreneur of the Year® 2012 Semifinalist MILWAUKEE–(BUSINESS WIRE)–Cynthia Dohmen LaConte named semin-finalist in E & Y’s Entrepreneur of the Year Upper Midwest. Navidea Biopharmaceuticals Announces First Quarter 2012 Results DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals (NYSE Amex: NAVB) Announces First Quarter 2012 Results: Business Update / Quarterly Conference Call [...]